ストックスクリーナーアプリを入手
229.52
0.18%
1.03
Abbvie Inc (ABBV) 最新ニュース
New year sees Abbvie, Zelgen in $1.1B T-cell engager deal - BioWorld MedTech
Ironwood boosts outlook on AbbVie's Linzess (update) (IRWD) - Seeking Alpha
Abbvie acquires cancer drug candidate for USD 100m - medwatch.com
Ironwood beats on 2026 outlook thanks to AbbVie-partnered Linzess - MSN
Here's How AbbVie's Neuroscience Portfolio Is Aiding Top-line Growth - Yahoo Finance
Zelgen Pharma inks licensing option agreement with AbbVie - The Pharma Letter
Silver Oak Securities Incorporated Raises Stock Position in AbbVie Inc. $ABBV - MarketBeat
What to Expect From AbbVie's Next Quarterly Earnings Report - Barchart.com
Generali Asset Management SPA SGR Decreases Stock Holdings in AbbVie Inc. $ABBV - MarketBeat
Banque Pictet & Cie SA Has $77.33 Million Stock Position in AbbVie Inc. $ABBV - MarketBeat
AbbVie: Solid Growth, Some Risks, And An Attractive Setup In 2026 - Seeking Alpha
AbbVie stock ends 2025 lower as markets shut for New Year — what ABBV investors watch next - ts2.tech
Miracle Mile Advisors LLC Has $13.65 Million Stock Position in AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. $ABBV Shares Bought by Los Angeles Capital Management LLC - MarketBeat
Nicholas Wealth LLC. Cuts Stock Holdings in AbbVie Inc. $ABBV - MarketBeat
Moody Lynn & Lieberson LLC Has $42.48 Million Holdings in AbbVie Inc. $ABBV - MarketBeat
Allspring Global Investments Holdings LLC Grows Position in AbbVie Inc. $ABBV - MarketBeat
The Truth About AbbVie Inc (ABBV): Quiet Pharma Giant, Loud Money Moves - AD HOC NEWS
10 Health Care Stocks Whale Activity In Today's Session - Benzinga
AbbVie (ABBV) Maintains Immunology Dominance as Analysts Downplay Competitive Threat From J&J’s Tremfya to Skyrizi Market Share - Insider Monkey
The Truth About AbbVie Inc: Is ABBV the Sleeper Stock Gen Z Is Sleeping On? - AD HOC NEWS
Here is What to Know Beyond Why AbbVie Inc. (ABBV) is a Trending Stock - Yahoo Finance
VIRGINIA RETIREMENT SYSTEMS ET Al Grows Stake in AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. $ABBV Shares Acquired by Smith Salley Wealth Management - MarketBeat
Generate Investment Management Ltd Increases Position in AbbVie Inc. $ABBV - MarketBeat
Simplify Asset Management Inc. Boosts Stock Holdings in AbbVie Inc. $ABBV - MarketBeat
Calamos Wealth Management LLC Has $3.41 Million Position in AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. $ABBV Shares Purchased by Brendel Financial Advisors LLC - MarketBeat
Diversified Trust Co Purchases 10,891 Shares of AbbVie Inc. $ABBV - MarketBeat
Zelgen Biopharma says it signs strategic partnership with Abbvie for development and commercialisation of Alveltamig - marketscreener.com
AbbVie (ABBV): Buy, Sell, or Hold Post Q3 Earnings? - Barchart.com
BofA cuts AbbVie (ABBV) target while maintaining neutral view - MSN
BofA Cuts AbbVie (ABBV) Target While Maintaining Neutral View - Insider Monkey
3 No-Brainer Dividend Stocks to Buy Right Now - The Motley Fool
AbbVie stock slips today as Fed minutes loom in thin year-end trade - ts2.tech
Judge Halts US Drug Discount Overhaul, Blocks 340B Rebate Plan - Benzinga
3 Dividend-Paying Pharma Stocks Worth Watching for Steady 2026 Gains - TradingView — Track All Markets
Fort Washington Investment Advisors Inc. OH Lowers Holdings in AbbVie Inc. $ABBV - MarketBeat
AbbVie (ABBV) Stock in December 2025: Atogepant Breakthrough, Q3 Beat and 2026 Outlook After Medicare Price Cuts - ts2.tech
AbbVie Stock (ABBV) Outlook: Drug‑Pricing Deal Headlines, Fresh Analyst Targets, and the 2026 Catalysts Investors Are Watching - ts2.tech
Long-Term Stock Portfolio: 10 Best Stocks for the Next Decade - Insider Monkey
AbbVie Stock: Dividend Giant Balances Humira Cliff, Immunology Momentum and Wall Street Optimism - AD HOC NEWS
Sowell Financial Services LLC Sells 8,716 Shares of AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. $ABBV Shares Sold by Sapient Capital LLC - MarketBeat
Meyer Handelman Co. Has $39.35 Million Stock Holdings in AbbVie Inc. $ABBV - MarketBeat
Carnegie Investment Counsel Purchases 25,146 Shares of AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. (NYSE:ABBV) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
AbbVie Stock (ABBV) Holds Near $230 as Year-End “Santa Rally” Takes Shape; Dividend Boost, Legal Headlines and 2026 Outlook in Focus - ts2.tech
Is AbbVie a Buy, Sell, or Hold in 2026? - Finviz
AbbVie Inc. $ABBV Shares Sold by Highland Capital Management LLC - MarketBeat
Aug Momentum: How AbbVie Inc stock reacts to job market dataJuly 2025 Weekly Recap & Reliable Price Action Trade Plans - moha.gov.vn
5,829 Shares in AbbVie Inc. $ABBV Bought by Regent Peak Wealth Advisors LLC - MarketBeat
World Investment Advisors Increases Position in AbbVie Inc. $ABBV - MarketBeat
United States Semaglutide Market Forecast and Company Analysis Report 2025-2033 Featuring Novo Nordisk, Eli Lilly and Co, AstraZeneca, Biocon, Johnson and Johnson, Pfizer, AbbVie, and SanofiResearchAndMarkets.com - The AI Journal
AbbVie Inc. $ABBV Shares Sold by Pacer Advisors Inc. - MarketBeat
Cwm LLC Has $87.91 Million Position in AbbVie Inc. $ABBV - MarketBeat
Clayton Financial Group LLC Takes $1.43 Million Position in AbbVie Inc. $ABBV - MarketBeat
The Zacks Analyst Blog AbbVie, The Coca-Cola, Chevron, ImmuCell and Precipio - Nasdaq
AbbVie Stock (ABBV) Before the Market Opens Dec. 26, 2025: Today’s News, Earnings Outlook, Dividend Update, and Analyst Forecasts - ts2.tech
AbbVie (ABBV) Stock on Dec. 25, 2025: After-Hours Check, Today’s Headlines, and What to Watch Before the Dec. 26 Open - ts2.tech
Swedbank AB Buys 40,781 Shares of AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. $ABBV Shares Purchased by Brookstone Capital Management - MarketBeat
AbbVie Inc. $ABBV Shares Bought by Global X Japan Co. Ltd. - MarketBeat
AbbVie Stock (ABBV) After Hours on Dec. 24, 2025: What Happened Today and What to Know Before the Next Market Open - ts2.tech
Top Stock Reports for AbbVie, Coca-Cola & Chevron - Nasdaq
0.25%
0.24%
大文字化:
|
ボリューム (24 時間):